Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells-Reference-Cited by-同舟云学术

Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells

Published:2014-09-27 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Thulasiraman Padmamalini,McAndrews Daniel J,Mohiudddin Imran Q

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-724.pdf

Reference92 articles.

1. Ripperger T, Gadzicki D, Meindl A, Schlegelberger B: Breast cancer susceptibility: current knowledge and implications for genetic counselling. Eur J Hum Genet. 2009, 17 (6): 722-731. 10.1038/ejhg.2008.212.

2. Brouckaert O, Wildiers H, Floris G, Neven P: Update on triple-negative breast cancer: prognosis and management strategies. Int J Womens Health. 2012, 4: 511-520.

3. Bayraktar S, Gluck S: Molecularly targeted therapies for metastatic triple-negative breast cancer. Breast Cancer Res Treat. 2013, 138 (1): 21-35. 10.1007/s10549-013-2421-5.

4. Chiorean R, Braicu C, Berindan-Neagoe I: Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth?. Breast. 2013, 22 (6): 1026-1033. 10.1016/j.breast.2013.08.007.

5. Engebraaten O, Vollan HK, Borresen-Dale AL: Triple-negative breast cancer and the need for new therapeutic targets. Am J Pathol. 2013, 183 (4): 1064-1074. 10.1016/j.ajpath.2013.05.033.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting Peroxisome Proliferator-Activated Receptor-β/δ, Reactive Oxygen Species and Redox Signaling with Phytocompounds for Cancer Therapy;Antioxidants & Redox Signaling;2024-08-01

2. Examining the expression of low-density lipoprotein receptor (LDLR) and low-density lipoprotein receptor-related protein 6 (LRP6) genes in breast cancer cell lines;MOL BIOL RES COMMUN;2024

3. A REVIEW IN CURCUMINOIDS: CHEMISTRY, ANTICANCER ACTIVITY AND FUTURE PROSPECTS;INDIAN DRUGS;2024-05-28

4. Plant-Derived Compounds for Breast Cancer Therapy;Advances in Medical Diagnosis, Treatment, and Care;2024-04-19

5. Evaluation of the theranostic characteristics of chitosan-decorated bismuth oxide nanoparticles conjugated curcumin and 5-aminolevulinic acid as a biocompatible targeted nanoplatform in CT and breast cancer radiation therapy;Journal of Drug Delivery Science and Technology;2024-02